Schizophrenia News and Research

Latest Schizophrenia News and Research

Allergan releases generic INVEGA (paliperidone extended-release tablets) in the U.S.

Allergan plc, a leading global pharmaceutical company, today announced that it has launched a generic version of Janssen's INVEGA (paliperidone extended-release tablets) in the U.S. Allergan is the first company to receive FDA approval for and launch a generic version of INVEGA, demonstrating the deep expertise of the Company's global generics R&D, regulatory and supply chain teams.

25 Sep 2015

Brain & Behavior Research Foundation announces recipients of NARSAD Young Investigator Grants

The Brain & Behavior Research Foundation today announced the award of its NARSAD Young Investigator Grants valued at more than $13 million to 191 of the world's most promising young scientists.

24 Sep 2015

Adult survivors of childhood posterior fossa brain tumors have low working memory

Adult survivors of childhood brain tumors have lower working memory performance compared to healthy adults, according to researchers at Georgia State University and Emory University.

24 Sep 2015

Reduced conflict-related brain activity linked to higher risk for psychosis

Researchers led by Bradley S. Peterson, MD, director of the Institute for the Developing Mind at Children's Hospital Los Angeles, have shown that lower levels of conflict-related brain activity are associated with a higher risk for later psychosis.

23 Sep 2015

Subtle differences in brain function make women react differently to negative emotions, shows research

Women react differently to negative images compared to men, which may be explained by subtle differences in brain function.

23 Sep 2015

Abnormal behaviour of BDNF and DTNBP1 genes linked to underlying cause of schizophrenia

Research led by scientists from Duke-NUS Graduate Medical School Singapore (Duke-NUS) has linked the abnormal behaviour of two genes (BDNF and DTNBP1) to the underlying cause of schizophrenia. These findings have provided a new target for schizophrenia treatment.

21 Sep 2015

Researchers identify protein that regulates neuron growth

An international team of researchers, led by scientists at the National University of Singapore (NUS), has identified a protein that regulates the growth of neurons by transporting key metabolic enzymes to the tips of neural cells.

18 Sep 2015

Precise mouse brain map may provide new insights into brain circuits and origins of mental illnesses

Scientists at Duke University have released a highly detailed model of connections in the mouse brain that could provide generations of neuroscientists new insights into brain circuits and origins of mental illness, such as depression and schizophrenia.

16 Sep 2015

AgeneBio's HOPE4MCI Phase 3 trial receives support from NIH

AgeneBio, a biopharmaceutical company developing innovative therapeutics for unserved patients battling neurodegeneration, announced today that its HOPE4MCI Phase 3 clinical trial has received support from the National Institutes of Health.

15 Sep 2015

Researchers examine neuroanatomical signature of schizophrenia in different ethnic groups

While it is known that the incidence and outward symptoms of schizophrenia are strongly influenced by ethnic factors--for instance, patients from Asian ethnicities are more likely to experience visual hallucinations, whereas patients from western cultures and Caucasian ethnicities are more likely to suffer from auditory hallucinations--it was unclear if brain deficits would differ amongst suffers from various ethnic backgrounds.

14 Sep 2015

Study evaluates effectiveness of hypnotherapy

Although hypnosis has existed for hundreds of years, today it is still difficult to clearly judge its usefulness in the medical domain.

10 Sep 2015

Novel research tool identifies link between negative symptoms of schizophrenia and adverse clinical outcomes

A novel research tool developed by researchers from the Institute of Psychiatry, Psychology & Neuroscience at King's College London has identified a link between the negative symptoms experienced by people with schizophrenia and adverse clinical outcomes.

8 Sep 2015

Ex-prisoners with common psychiatric disorders more likely to commit violent crimes after release

Ex-prisoners with common psychiatric disorders such as bipolar disorder (manic-depressive disorder) and alcohol and drug abuse are substantially more likely to commit a violent crime after release than other prisoners, according to new research published in The Lancet Psychiatry journal.

4 Sep 2015

Researchers reveal how the brain manages multitasking

What makes someone better at switching between different tasks? Looking for the mechanisms behind cognitive flexibility, researchers at the University of Pennsylvania and Germany's Central Institute of Mental Health in Mannheim and Charité University Medicine Berlin have used brain scans to shed new light on this question.

2 Sep 2015

Phase III trial results show cariprazine effective in treating negative symptoms associated with schizophrenia

Results of a clinical trial seem to show the first effective treatment for the negative symptoms - withdrawal, lack of emotion, and apathy - associated with schizophrenia.

31 Aug 2015

Single dose of cocaine can impair ability to recognise negative emotions

A single dose of cocaine can interfere with the ability to recognise negative emotions, according to new research presented at the ECNP conference in Amsterdam.

31 Aug 2015

Brain scans may help predict patients' response to antipsychotic drug treatment

Investigators at The Feinstein Institute for Medical Research have discovered that brain scans can be used to predict patients' response to antipsychotic drug treatment. The findings are published online in the latest issue of The American Journal of Psychiatry.

28 Aug 2015

Brain cells in Parkinson's disease die prematurely, burning out like an overheating motor

The death of brain cells in Parkinson's disease may be caused by a form of cellular energy crisis in neurons that require unusually high quantities of energy to carry out their job of regulating movement, researchers at the University of Montreal reported today.

28 Aug 2015

UiO researchers test new nasal spray device for treating mental illness

Researchers at the University of Oslo have tested a new device for delivering hormone treatments for mental illness through the nose. This method was found to deliver medicine to the brain with few side effects.

27 Aug 2015

Automated speech analysis program correctly identifies young people at risk for psychosis

An automated speech analysis program correctly differentiated between at-risk young people who developed psychosis over a two-and-a-half year period and those who did not. In a proof-of-principle study, researchers at Columbia University Medical Center, New York State Psychiatric Institute, and the IBM T. J. Watson Research Center found that the computerized analysis provided a more accurate classification than clinical ratings.

27 Aug 2015

Schizophrenia News and Research

Latest Schizophrenia News and Research

Allergan releases generic INVEGA (paliperidone extended-release tablets) in the U.S.

Brain & Behavior Research Foundation announces recipients of NARSAD Young Investigator Grants

Adult survivors of childhood posterior fossa brain tumors have low working memory

Reduced conflict-related brain activity linked to higher risk for psychosis

Subtle differences in brain function make women react differently to negative emotions, shows research

Abnormal behaviour of BDNF and DTNBP1 genes linked to underlying cause of schizophrenia

Researchers identify protein that regulates neuron growth

Precise mouse brain map may provide new insights into brain circuits and origins of mental illnesses

AgeneBio's HOPE4MCI Phase 3 trial receives support from NIH

Researchers examine neuroanatomical signature of schizophrenia in different ethnic groups

Study evaluates effectiveness of hypnotherapy

Novel research tool identifies link between negative symptoms of schizophrenia and adverse clinical outcomes

Ex-prisoners with common psychiatric disorders more likely to commit violent crimes after release

Researchers reveal how the brain manages multitasking

Phase III trial results show cariprazine effective in treating negative symptoms associated with schizophrenia

Single dose of cocaine can impair ability to recognise negative emotions

Brain scans may help predict patients' response to antipsychotic drug treatment

Brain cells in Parkinson's disease die prematurely, burning out like an overheating motor

UiO researchers test new nasal spray device for treating mental illness

Automated speech analysis program correctly identifies young people at risk for psychosis

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Schizophrenia News and Research

Latest Schizophrenia News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in